Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rapid Dose Therapeutics Corp (TSE:DOSE)
CNQX:DOSE
Holding TSE:DOSE?
Track your performance easily
DOSE Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.09 - C$0.33
Previous CloseC$0.22
Volume61.77K
Average Volume (3M)58.48K
Market Cap
C$27.42M
Enterprise ValueC$27.35M
Total Cash (Recent Filing)C$71.68K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta-0.37
Next Earnings
Feb 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding128,442,072
10 Day Avg. Volume52,353
30 Day Avg. Volume58,484
Standard Deviation0.38
R-Squared0.00858
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-7.33
Price to Sales (P/S)21.07
Price to Cash Flow (P/CF)-27.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Rapid Dose Therapeutics Corp News
PremiumCompany Announcements
Rapid Dose Therapeutics Unveils Lidocaine Oral Strip Innovation
PremiumCompany Announcements
Rapid Dose Therapeutics Issues Shares for Debt Interest
PremiumCompany Announcements
Rapid Dose Therapeutics Extends Financing Window
PremiumCompany Announcements
Rapid Dose Therapeutics Appoints New Director
PremiumCompany Announcements
Rapid Dose Therapeutics Secures Initial Funding
PremiumCompany Announcements
Rapid Dose Therapeutics to Settle Interest with Shares
PremiumCompany Announcements
Rapid Dose Therapeutics Sees Revenue Surge
PremiumCompany Announcements
Rapid Dose Therapeutics Innovates Vaccine DeliveryOptions Prices
Currently, No data available
---
Ownership Overview
DOSE FAQ
What was Rapid Dose Therapeutics Corp’s price range in the past 12 months?
Rapid Dose Therapeutics Corp lowest stock price was C$0.09 and its highest was C$0.33 in the past 12 months.
What is Rapid Dose Therapeutics Corp’s market cap?
Currently, no data Available
When is Rapid Dose Therapeutics Corp’s upcoming earnings report date?
Rapid Dose Therapeutics Corp’s upcoming earnings report date is Feb 03, 2025 which is in 42 days.
How were Rapid Dose Therapeutics Corp’s earnings last quarter?
Rapid Dose Therapeutics Corp released its earnings results on Oct 30, 2024. The company reported -C$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.009.
Is Rapid Dose Therapeutics Corp overvalued?
According to Wall Street analysts Rapid Dose Therapeutics Corp’s price is currently Overvalued.
Does Rapid Dose Therapeutics Corp pay dividends?
Rapid Dose Therapeutics Corp does not currently pay dividends.
What is Rapid Dose Therapeutics Corp’s EPS estimate?
Rapid Dose Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rapid Dose Therapeutics Corp have?
Rapid Dose Therapeutics Corp has 124,636,170 shares outstanding.
What happened to Rapid Dose Therapeutics Corp’s price movement after its last earnings report?
Rapid Dose Therapeutics Corp reported an EPS of -C$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.571%.
Which hedge fund is a major shareholder of Rapid Dose Therapeutics Corp?
Currently, no hedge funds are holding shares in TSE:DOSE
---
Rapid Dose Therapeutics Corp Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
62.96%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-18.12%
Trailing 12-Months
Company Description
Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp is a bio-technology company, which through its subsidiaries, provides proprietary enhanced drug delivery technologies designed to improve patient outcomes. The company through its subsidiary, owns a proprietary oral fast-dissolving drug delivery system, QuickStrip, which is capable of rapidly releasing into the blood stream a variety of pharmaceuticals, emulsified oils and over-the-counter medicines without being degraded or modified by first pass metabolism in the liver.
---
Technical Analysis
---